The Department of Defense is offering this grant through its Spinal Cord Injury Research Program (SCIRP) to support clinical trials aiming for significant impact on spinal cord injury (SCI) treatment or management. This grant is specifically for clinical trials involving the prospective accrual of human subjects, where an intervention (such as a device, drug, surgical procedure, or rehabilitative modality) is tested for measurable outcomes regarding safety, effectiveness, or efficacy. Funds from this award mechanism must exclusively support clinical research and cannot be used for preclinical studies. Principal Investigators focused on preclinical projects should explore other funding opportunities from the DoD. This grant is for the purpose of advancing direct interventions that benefit human subjects with SCI.
Opportunity ID: 294432
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-17-SCIRP-CTA |
Funding Opportunity Title: | DoD Spinal Cord Injury Research Program, Clinical Trial Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Jun 06, 2017 |
Last Updated Date: | Oct 20, 2017 |
Original Closing Date for Applications: | Nov 29, 2017 |
Current Closing Date for Applications: | Nov 29, 2017 |
Archive Date: | Dec 29, 2017 |
Estimated Total Program Funding: | $12,800,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The SCIRP CTA supports research with the potential to have a major impact on the treatment or management of SCI. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other award mechanisms/funding opportunities being offered. The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at the electronic Biomedical Research Application Portal (eBRAP) (https://ebrap.org/eBRAP/public/Program.htm). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
The purpose of this modification is to include the Investigational New Drug (IND) or Investigational Device Exemption (IDE) Documentation Form. No other revisions have been made. | Oct 20, 2017 | |
Modification to correct the estimated total program funding. | Oct 20, 2017 | |
Jun 06, 2017 |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-17-SCIRP-CTA |
Funding Opportunity Title: | DoD Spinal Cord Injury Research Program, Clinical Trial Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Jun 06, 2017 |
Last Updated Date: | Oct 20, 2017 |
Original Closing Date for Applications: | Nov 29, 2017 |
Current Closing Date for Applications: | Nov 29, 2017 |
Archive Date: | Dec 29, 2017 |
Estimated Total Program Funding: | $12,800,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The SCIRP CTA supports research with the potential to have a major impact on the treatment or management of SCI. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other award mechanisms/funding opportunities being offered. The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at the electronic Biomedical Research Application Portal (eBRAP) (https://ebrap.org/eBRAP/public/Program.htm). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-17-SCIRP-CTA |
Funding Opportunity Title: | DoD Spinal Cord Injury Research Program, Clinical Trial Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Oct 20, 2017 |
Last Updated Date: | Jun 06, 2017 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Nov 29, 2017 |
Archive Date: | Dec 29, 2017 |
Estimated Total Program Funding: | $12,800,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The SCIRP CTA supports research with the potential to have a major impact on the treatment or management of SCI. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other award mechanisms/funding opportunities being offered. The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at the electronic Biomedical Research Application Portal (eBRAP) (https://ebrap.org/eBRAP/public/Program.htm). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-17-SCIRP-CTA |
Funding Opportunity Title: | DoD Spinal Cord Injury Research Program, Clinical Trial Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jun 06, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Nov 29, 2017 |
Archive Date: | Dec 29, 2017 |
Estimated Total Program Funding: | $30,000,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The SCIRP CTA supports research with the potential to have a major impact on the treatment or management of SCI. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other award mechanisms/funding opportunities being offered. The term “human subjects” is used in this Program Announcement to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at the electronic Biomedical Research Application Portal (eBRAP) (https://ebrap.org/eBRAP/public/Program.htm). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Related Documents
Folder 294432 Full Announcement-FY17 SCIRP CTA -> IND_IDE_ Documentation Form.pdf
Folder 294432 Full Announcement-FY17 SCIRP CTA -> SCIRP_FY17_CTA_PA_GG.pdf
Packages
Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00233010 | Jun 06, 2017 | Nov 29, 2017 | View |
Package 1
Mandatory forms
294432 RR_SF424_2_0-2.0.pdf
294432 RR_Budget_1_4-1.4.pdf
294432 RR_KeyPersonExpanded_2_0-2.0.pdf
294432 PerformanceSite_2_0-2.0.pdf
294432 AttachmentForm_1_2-1.2.pdf
Optional forms
294432 RR_SubawardBudget30_1_4-1.4.pdf